Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients
Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, View ORCID ProfileGerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Judith A. Burger, Joey H. Bouhuijs, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Mirjam H.M. Heemskerk, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, View ORCID ProfileMarit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof the COBRA KAI study team
doi: https://doi.org/10.1101/2022.04.08.22273602
Sabine Haggenburg
1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
2Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands
MDQuincy Hofsink
1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
2Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands
MDBirgit I. Lissenberg-Witte
3Department of Epidemiology and Data Science, Amsterdam UMC location Vrije Universiteit, Amsterdam, The Netherlands
PhDAnnoek E.C. Broers
4Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
MD, PhDJaap A. van Doesum
5Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
MDRob S. van Binnendijk
6Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
PhDGerco den Hartog
6Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
PhDMichel S. Bhoekhan
1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
2Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands
BScNienke J.E. Haverkate
2Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands
7Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
BScJudith A. Burger
8Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
BScJoey H. Bouhuijs
8Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
BScGaby P. Smits
6Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
MScDorine Wouters
9Central Diagnostic Laboratory, Amsterdam UMC, Amsterdam, The Netherlands
PhDEster M.M. van Leeuwen
2Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands
7Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
PhDHetty J. Bontkes
10Laboratory Medical Immunology, Amsterdam UMC, Amsterdam, The Netherlands
PhDNeeltje A. Kootstra
2Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands
7Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
PhDSonja Zweegman
11Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, The Netherlands
12Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
MD, PhDArnon P. Kater
1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
12Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
MD, PhDMirjam H.M. Heemskerk
13Department of Hematology, Leiden UMC, Leiden, The Netherlands
PhDKaz Groen
11Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, The Netherlands
MDTom van Meerten
5Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
MD PhDPim G.N.J. Mutsaers
4Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
MDTim Beaumont
8Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
PhDMarit J. van Gils
8Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
PhDAbraham Goorhuis
14Department of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
MD PhDCaroline E. Rutten
1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
MD PhDMette D. Hazenberg
1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
2Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands
12Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
15Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands
MD PhDInger S. Nijhof
11Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, The Netherlands
16Department of Internal Medicine-Hematology, St. Antonius Hospital, Nieuwegein, The Netherlands
MD PhD
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted April 18, 2022.
Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients
Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Judith A. Burger, Joey H. Bouhuijs, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Mirjam H.M. Heemskerk, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof
medRxiv 2022.04.08.22273602; doi: https://doi.org/10.1101/2022.04.08.22273602
Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients
Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Judith A. Burger, Joey H. Bouhuijs, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Mirjam H.M. Heemskerk, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof
medRxiv 2022.04.08.22273602; doi: https://doi.org/10.1101/2022.04.08.22273602
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2930)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12734)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4577)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (424)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4344)
- Nursing (236)
- Nutrition (638)
- Oncology (2266)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1525)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)